» Articles » PMID: 9659816

HMGI Family Proteins: Architectural Transcription Factors in Mammalian Development and Cancer

Overview
Journal Keio J Med
Specialty General Medicine
Date 1998 Jul 11
PMID 9659816
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The HMGI proteins, a subfamily of the high mobility group (HMG) proteins, play an important role in the regulation of gene expression. They bind to AT-rich DNA sequences and alter DNA conformation to modulate the binding affinity of transcription factors to their cognate sites. They are expressed almost exclusively during embryogenesis and Hmgi-c null mice have the mouse pygmy phenotype. Studies have revealed the disruption of HMGI family genes in a variety of mesenchymal-derived benign tumors. Therefore, the HMGI genes function in the coordination of cell proliferation and differentiation during mammalian development.

Citing Articles

Inhibition of HMGA2 binding to AT-rich DNA by its negatively charged C-terminus.

Su L, Deng Z, Santos-Fernandez M, Jeanne Dit Fouque K, Chapagain P, Chambers J Nucleic Acids Res. 2025; 53(3).

PMID: 39873271 PMC: 11773362. DOI: 10.1093/nar/gkaf035.


Rare germline disorders implicate long non-coding RNAs disrupted by chromosomal structural rearrangements.

Andersen R, Alkuraya I, Ajeesh A, Sakamoto T, Mena E, Amr S medRxiv. 2024; .

PMID: 38946951 PMC: 11213069. DOI: 10.1101/2024.06.16.24307499.


Novel ancestry-specific primary open-angle glaucoma loci and shared biology with vascular mechanisms and cell proliferation.

Lo Faro V, Bhattacharya A, Zhou W, Zhou D, Wang Y, Lall K Cell Rep Med. 2024; 5(2):101430.

PMID: 38382466 PMC: 10897632. DOI: 10.1016/j.xcrm.2024.101430.


HMGA2 promotes cancer metastasis by regulating epithelial-mesenchymal transition.

Ma Q, Ye S, Liu H, Zhao Y, Mao Y, Zhang W Front Oncol. 2024; 14:1320887.

PMID: 38361784 PMC: 10867147. DOI: 10.3389/fonc.2024.1320887.


miR-219-5p attenuates cisplatin resistance of ovarian cancer by inactivating Wnt/β-catenin signaling and autophagy via targeting HMGA2.

Song Z, Liao C, Yao L, Xu X, Shen X, Tian S Cancer Gene Ther. 2022; 30(4):596-607.

PMID: 36494581 DOI: 10.1038/s41417-022-00574-y.